Neovasc Provides Corporate Update Following Clinical Data Release
September 20, 2022 09:05 ET
|
Neovasc, Inc.
New Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease VANCOUVER and MINNEAPOLIS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the...
Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit
September 16, 2022 09:00 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Sept. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be...
Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina
September 15, 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Sept. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today commented on the Centers for Medicare and...
Neovasc Announces Key Events at TCT 2022
September 08, 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced its participation and presence at the...
Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference
August 30, 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Aug. 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be...
Neovasc Announces Second Quarter Financial Results and Provides Corporate Update
August 11, 2022 16:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Aug. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the second quarter...
Neovasc to Report Second Quarter Financial Results on August 11, 2022
July 28, 2022 09:00 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (NASDAQ , TSX : NVCN), will report financial results for the quarter ended June 30, 2022 on Thursday,...
Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations
July 26, 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced the United States Food and Drug...
Neovasc Announces Direct Sales Operations in United Kingdom
July 05, 2022 09:05 ET
|
Neovasc, Inc.
Expansion Driven by NICE Guidelines and Enhanced Reimbursement for the Neovasc Reducer™ VANCOUVER and MINNEAPOLIS, July 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. ("Neovasc" or...
Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference
June 08, 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, June 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be...